These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 23486330)

  • 1. A rare case of ectopic adrenocorticotropic hormone syndrome caused by a metastatic neuroendocrine tumor of the pancreas detected by 68Ga-DOTANOC and 18F-FDG PET/CT.
    Treglia G; Salomone E; Petrone G; Giaccari A; Rindi G; Rufini V
    Clin Nucl Med; 2013 Jul; 38(7):e306-8. PubMed ID: 23486330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual tracer functional imaging of gastroenteropancreatic neuroendocrine tumors using 68Ga-DOTA-NOC PET-CT and 18F-FDG PET-CT: competitive or complimentary?
    Naswa N; Sharma P; Gupta SK; Karunanithi S; Reddy RM; Patnecha M; Lata S; Kumar R; Malhotra A; Bal C
    Clin Nucl Med; 2014 Jan; 39(1):e27-34. PubMed ID: 24217539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ectopic ACTH and CRH Co-secreting Tumor Localized by 68Ga-DOTA-TATE PET/CT.
    Papadakis GZ; Bagci U; Sadowski SM; Patronas NJ; Stratakis CA
    Clin Nucl Med; 2015 Jul; 40(7):576-8. PubMed ID: 26018709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphoma as a second malignancy in a patient with neuroendocrine tumor: mimicking dedifferentiation on dual-tracer PET/CT with 68Ga-DOTANOC and 18F-FDG.
    Jain S; Sharma P; Dhull VS; Bal C; Kumar R
    Clin Nucl Med; 2014 Apr; 39(4):358-9. PubMed ID: 24217543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An unusual case of ectopic ACTH syndrome due to primary retroperitoneal carcinoid.
    Kasaliwal R; Malhotra G; Lila A; Bandgar T; Shah NS
    Clin Nucl Med; 2015 Apr; 40(4):364-7. PubMed ID: 25608172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can complementary 68Ga-DOTATATE and 18F-FDG PET/CT establish the missing link between histopathology and therapeutic approach in gastroenteropancreatic neuroendocrine tumors?
    Has Simsek D; Kuyumcu S; Turkmen C; Sanlı Y; Aykan F; Unal S; Adalet I
    J Nucl Med; 2014 Nov; 55(11):1811-7. PubMed ID: 25315243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative characterization of indeterminate large adrenal masses with dual tracer PET-CT using fluorine-18 fluorodeoxyglucose and gallium-68-DOTANOC: initial results.
    Naswa N; Sharma P; Soundararajan R; Patnecha M; Lata S; Kumar R; Malhotra A; Bal C
    Diagn Interv Radiol; 2013; 19(4):294-8. PubMed ID: 23439252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of 68Ga-DOTANOC and 68Ga-DOTATATE PET/CT within patients with gastroenteropancreatic neuroendocrine tumors.
    Wild D; Bomanji JB; Benkert P; Maecke H; Ell PJ; Reubi JC; Caplin ME
    J Nucl Med; 2013 Mar; 54(3):364-72. PubMed ID: 23297077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multifocal extra-adrenal paraganglioma evaluated with different PET tracers: comparison between 18F-FDG, 18F-DOPA and 68Ga DOTANOC PET/CT.
    Treglia G; Cardillo G; Stefanelli A; Di Franco D; Enang GN; Giordano A; Rufini V
    Clin Nucl Med; 2013 Dec; 38(12):e458-62. PubMed ID: 23486329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of 68Ga-DOTANOC and 18F-FDG PET-CT Scans in the Evaluation of Primary Tumors and Lymph Node Metastasis in Patients With Rectal Neuroendocrine Tumors.
    Zhou Z; Wang Z; Zhang B; Wu Y; Li G; Wang Z
    Front Endocrinol (Lausanne); 2021; 12():727327. PubMed ID: 34539577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the Added Value of Diffusion-Weighted Imaging to Conventional Magnetic Resonance Imaging in Pancreatic Neuroendocrine Tumors and Comparison With 68Ga-DOTANOC Positron Emission Tomography/Computed Tomography.
    Farchione A; Rufini V; Brizi MG; Iacovazzo D; Larghi A; Massara RM; Petrone G; Poscia A; Treglia G; De Marinis L; Giordano A; Rindi G; Bonomo L
    Pancreas; 2016 Mar; 45(3):345-54. PubMed ID: 26418904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 68Ga DOTANOC PET/CT in primary neuroendocrine tumor of the breast.
    Mukherjee A; Karunanithi S; Singla S; Bal C; Kumar R
    Clin Nucl Med; 2014 Apr; 39(4):396-8. PubMed ID: 24566407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneity of Multiple Pancreatic Neuroendocrine Tumors Identified by 68Ga-DOTANOC and 68Ga-Exendin-4 PET/CT in a Patient with Endogenous Hyperinsulinemic Hypoglycemia and Multiple Endocrine Neoplasia 1.
    Xu J; Xu X; Zhang M; Liu W; Chen J; Song S
    Neuroendocrinology; 2024; 114(9):866-871. PubMed ID: 38471465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined 18F-FDG PET/CT and 68Ga DOTATATE PET/CT "Superscan" in Metastatic Pancreatic Neuroendocrine Tumor.
    Chan M; Schembri GP
    Clin Nucl Med; 2017 Feb; 42(2):108-109. PubMed ID: 27997429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 18Flurodeoxyglucose positron emission tomography in the localization of ectopic ACTH-secreting neuroendocrine tumours.
    Kumar J; Spring M; Carroll PV; Barrington SF; Powrie JK
    Clin Endocrinol (Oxf); 2006 Apr; 64(4):371-4. PubMed ID: 16584507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. When should F-18 FDG PET/CT be used instead of 68Ga-DOTA-peptides to investigate metastatic neuroendocrine tumors?
    Fuccio C; Musto A; Cambioli S; Castellucci P; Pantaleo MA; Nanni C; Montini GC; Campana D; Tomassetti P; Bellan E; Massaro A; Grassetto G; Rubello D; Fanti S
    Clin Nucl Med; 2011 Dec; 36(12):1109-11. PubMed ID: 22064082
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of the prognostic values of 68Ga-DOTANOC PET/CT and 18F-FDG PET/CT in patients with well-differentiated neuroendocrine tumor.
    Sharma P; Naswa N; Kc SS; Alvarado LA; Dwivedi AK; Yadav Y; Kumar R; Ammini AC; Bal C
    Eur J Nucl Med Mol Imaging; 2014 Dec; 41(12):2194-202. PubMed ID: 25030618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual-tracer PET/CT imaging to determine tumor heterogeneity in a patient with metastatic ACTH-secreting neuroendocrine neoplasm: A case report and literature review.
    Ryzhkova D; Mitrofanova L; Tsoy U; Grineva E; Schlyakhto E
    Front Endocrinol (Lausanne); 2022; 13():958442. PubMed ID: 36133304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of F18-fluorodeoxyglycose positron emission tomography/computed tomography on the management of resectable pancreatic tumours.
    Yao J; Gan G; Farlow D; Laurence JM; Hollands M; Richardson A; Pleass HC; Lam VW
    ANZ J Surg; 2012 Mar; 82(3):140-4. PubMed ID: 22510123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of diagnostic efficacy of
    Zhang B; He Q; Long Y; Zhang Y; Wang X; Chen Z; Liu J; Zhang X
    Front Endocrinol (Lausanne); 2022; 13():962800. PubMed ID: 36213295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.